SNPHFOTCHealthcare · Drug Manufacturers - General

Santen Pharmaceutical Co., Ltd.

$10.99+0.00%(+$0.00)

TickerSpark Score

84/100

Strong

Valuation

Profitability

Growth

Health

100

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SNPHF research report →

52-Week Range82% of range

Low $8.88

Current $10.99

High $11.45

Companywww.santen.com

Santen Pharmaceutical Co. , Ltd. researches and develops, manufactures, and markets pharmaceuticals and medical devices in Japan and internationally.

CEO: Takeshi Ito
IPO: 2010
Employees: 3,744
HQ: Osaka, JP

Price Chart

+9.57% · this period

Valuation

Market Cap: $3.54B
P/E: 16.49
P/S: 2.09
P/B: 2.07
EV/EBITDA: 8.32
Div Yield: 2.00%

Profitability

Gross Margin: 55.20%
Op Margin: 15.50%
Net Margin: 12.81%
ROE: 13.15%
ROIC: 10.68%

Growth & Income

Revenue: $293.46B · -2.18%
Net Income: $37.60B · 3.72%
EPS: $115.04 · 10.64%
Op Income: $45.50B
FCF YoY: -32.03%

Performance & Tape

52W High: $11.45
52W Low: $8.88
50D MA: $10.93
200D MA: $10.46
Beta: 0.23
Avg Volume: 32

Get TickerSpark's AI analysis on SNPHF

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime